MoonLake Immunotherapeutics amends equity plans to provide automatic vesting upon change of control

MoonLake Immunotherapeutics

Effective May 15, 2023, Board amended Employee Share Participation Plan and Stock Option Plan to include single-trigger vesting upon Change of Control.
Amendments apply to all outstanding and future equity awards, including those to named executive officers.
Awards will vest in full automatically upon a Change of Control as defined in the Plans.
Change aligns compensation arrangements with market practice per the Company's review.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.